Literature DB >> 12834515

Psychopathological features in Alzheimer's disease: course and relationship with cognitive status.

Roee Holtzer1, Ming-Xin Tang, D P Devanand, Steven M Albert, Domonick J Wegesin, Karen Marder, Karen Bell, Marilyn Albert, Jason Brandt, Yaakov Stern.   

Abstract

OBJECTIVES: To examine the course, clinical correlates, and relationship between cognitive status and psychopathological features in patients with probable Alzheimer's disease (AD) followed over a 5-year period.
DESIGN: Cohort study with follow-up of 5 years.
SETTING: Patients were recruited at three sites: 91 patients at Columbia Medical Center, 84 at Johns Hopkins School of Medicine, and 61 at Massachusetts General Hospital. PARTICIPANTS: Patients diagnosed with probable AD (n = 236) enrolled in a longitudinal study (Predictors study). MEASUREMENTS: Wandering/agitation, physical aggression, hallucinations, and delusions were evaluated at 6-month intervals using the Columbia Scale for Psychopathology in Alzheimer's Disease. Descriptive analyses were used to provide estimates of prevalence and course of psychopathological features. General estimating equations determined the odds of having any of the four psychopathological behaviors as a function of cognitive status. Markov analyses provided 6-month transition probabilities for psychopathological behaviors given patients' cognitive status and the presence or absence of such behaviors in the previous evaluation.
RESULTS: For wandering/agitation, prevalence (39-57%) and persistence increased as a function of time and decrement in cognitive status. Physical aggression was less prevalent (6-22%) and increased as a function of cognitive decline but tended to persist only in the more severely impaired patients. Delusions (34-49%) reached a peak at the second year and then declined. The odds of delusions were maximal with intermediate decline but remained persistent regardless of cognitive status. Hallucinations, despite some fluctuations, were relatively stable during the follow-up period (8-17%) and moderately persistent.
CONCLUSION: Psychopathological features, particularly wandering/agitation and delusions, in AD were common throughout the disease course. The natural history and persistence of the four psychopathological features varied. These findings provide important information to clinicians and caregivers regarding the course, predictability, and possible treatment of psychopathological behaviors in patients with probable AD.

Entities:  

Mesh:

Year:  2003        PMID: 12834515     DOI: 10.1046/j.1365-2389.2003.51308.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  22 in total

1.  Estimation and validation of a multiattribute model of Alzheimer disease progression.

Authors:  Eric Stallard; Bruce Kinosian; Arthur S Zbrozek; Anatoliy I Yashin; Henry A Glick; Yaakov Stern
Journal:  Med Decis Making       Date:  2010 Nov-Dec       Impact factor: 2.583

2.  Aggression in persons with dementia: use of nursing theory to guide clinical practice.

Authors:  Diane Dettmore; Ann Kolanowski; Malaz Boustani
Journal:  Geriatr Nurs       Date:  2009 Jan-Feb       Impact factor: 2.361

3.  Nonpharmacologic management of behavioral symptoms in dementia.

Authors:  Laura N Gitlin; Helen C Kales; Constantine G Lyketsos
Journal:  JAMA       Date:  2012-11-21       Impact factor: 56.272

4.  Delusions and hallucinations are associated with worse outcome in Alzheimer disease.

Authors:  Nikolaos Scarmeas; Jason Brandt; Marilyn Albert; Georgios Hadjigeorgiou; Alexandros Papadimitriou; Bruno Dubois; Maria Sarazin; Davangere Devanand; Lawrence Honig; Karen Marder; Karen Bell; Domonick Wegesin; Deborah Blacker; Yaakov Stern
Journal:  Arch Neurol       Date:  2005-10

Review 5.  The economic impact of neuropsychiatric symptoms in Alzheimer's disease: can drugs ease the burden?

Authors:  Daniel L Murman; Christopher C Colenda
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

6.  Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.

Authors:  Alexandre Y Dombrovski; Benoit H Mulsant; Robert E Ferrell; Francis E Lotrich; Jules I Rosen; Meredith Wallace; Patricia R Houck; Sati Mazumdar; Bruce G Pollock
Journal:  Int Clin Psychopharmacol       Date:  2010-01       Impact factor: 1.659

7.  Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.

Authors:  Katherine A Treiber; Constantine G Lyketsos; Chris Corcoran; Martin Steinberg; Maria Norton; Robert C Green; Peter Rabins; David M Stein; Kathleen A Welsh-Bohmer; John C S Breitner; JoAnn T Tschanz
Journal:  Int Psychogeriatr       Date:  2008-02-21       Impact factor: 3.878

8.  Learning From The Past and Planning For The Future: The Challenges Of And Solutions For Integrating Aging Into Doctoral Psychology Training.

Authors:  Roee Holtzer; Richard A Zweig; Lawrence J Siegel
Journal:  Train Educ Prof Psychol       Date:  2012-08-01

9.  Disruptive behavior as a predictor in Alzheimer disease.

Authors:  Nikolaos Scarmeas; Jason Brandt; Deborah Blacker; Marilyn Albert; Georgios Hadjigeorgiou; Bruno Dubois; Davangere Devanand; Lawrence Honig; Yaakov Stern
Journal:  Arch Neurol       Date:  2007-12

10.  Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.

Authors:  Martin Steinberg; Kyle Hess; Chris Corcoran; Michelle M Mielke; Maria Norton; John Breitner; Robert Green; Jeannie Leoutsakos; Kathleen Welsh-Bohmer; Constantine Lyketsos; Joann Tschanz
Journal:  Int J Geriatr Psychiatry       Date:  2013-05-17       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.